Patent ID: 8937165
Filing Date: 2015-01-20
Classification: C12Q,G01N

Abstract:
1. An isolated composition for early diagnosis of liver cancer comprising materials that can detect the presence, and expression levels, expression patterns or both of proteomic markers APOA1 isoform CRA b (apolipoprotein A-I, isoform CRA_b; NCBI GI:119587681); AKR1C4_HUMAN (Aldo-keto reductase family 1 member C4 (Chlordecone reductase)(CDR); NCBI GI:1705823); VCL_HUMAN (vinculin; NCBI GI:4507877); GLE1_HUMAN (GLE1 RNA export mediator homolog isoform 2; NCBI GI:4557627); and TOR1A1 P1_HUMAN (torsin A interacting protein 1, isoform CRA_b; NCBI GI:119611474) wherein the materials are a population of isolated antibodies that can specifically detect proteomic markers for early detection of liver cancer.